Carmignac Gestion’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-254,777
Closed -$117M 150
2023
Q4
$117M Sell
254,777
-2,160
-0.8% -$1.06M 1.96% 15
2023
Q3
$125M Sell
256,937
-61,007
-19% -$28.7M 2.3% 15
2023
Q2
$142M Buy
317,944
+75,198
+31% +$37.9M 2.45% 11
2023
Q1
$118M Sell
242,746
-38,583
-14% -$19.1M 1.96% 20
2022
Q4
$144M Sell
281,329
-9,579
-3% -$5.03M 2.6% 13
2022
Q3
$141M Sell
290,908
-67,443
-19% -$32.8M 3.03% 13
2022
Q2
$168M Buy
358,351
+125,139
+54% +$55.7M 3.55% 12
2022
Q1
$101M Buy
+233,212
New +$97.6M 1.64% 21

Other funds holding HUM

Carmignac Gestion's HUM Position: Q1 2024 in Review

Carmignac Gestion sold out of Humana (HUM) in Q1 2024, closing a stake of 254,777 shares — an estimated $117M sold.

Carmignac Gestion first reported a position in HUM in Q1 2022 and held it in 8 quarters. The position peaked at $168M in Q2 2022. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Carmignac Gestion reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Carmignac Gestion sold 254,777 Humana shares in Q1 2024, an estimated $117M.
  • Carmignac Gestion first reported a position in Humana in Q1 2022 and held it in 8 quarters.
  • Carmignac Gestion's Humana position peaked at $168M in Q2 2022.
  • 1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Carmignac Gestion's 13F filing for Q1 2024, filed 14 May 2024.